Paradoxical reactions in HIV and pulmonary TB

Chest

Volumn 114, Issue 3, 1998, Pages 933-936

  Chien, Jason W ^a,b   Johnson, John L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Antiretroviral therapy; HIV; Immune reconstitution; Lymphadenopathy; Mycobacterium tuberculosis; Paradoxical reaction

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0031691664     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3.933     Document Type: Article

References (12)

1. Carter EJ, Mates S. Sudden enlargement of a deep cervical lymph node during and after treatment for pulmonary tuberculosis. Chest 1994; 106:1896-1898
2. Teoh R, Humphries MJ, O'Mahony G. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med 1987; 63:449-460
3. British Thoracic Society Research Committee. Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. BMJ 1985; 290:1106-1108
4. Moreno C, Taverne J, Mehlert A, et al. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol 1989; 76:240-245
5. Rooney JJ, Crocco JA, Kramer S, et al. Further observations on tuberculin reactions in active tuberculosis. Am J Med 1976; 60:517-522
6. Narita M, Ashkin D, Hollender ES, et al. Transient worsening of systemic signs and symptoms after antiretroviral therapy in patients with tuberculosis and AIDS [abstract]. Am J Respir Crit Care Med 1997; 155(part 2):A255
7. Zhang M, Gong J, Iyer DV, et al. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-2442
8. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1997; 334:1011-1017
9. Rouleau D, Montaner JSG, Conway B, et al. Predictors of viral load response in a pilot open label study of stavudine (d4T) in combination with lamivudine (3TC) [abstract]. Fourth Conference on Retroviruses and Opportunistic Infection 1997; Jan 22-26:167
10. Lederman M, Connick E, Landay A, et al. Partial immune reconstitution after 12 weeks of HAART (AZT, 3TC, ritonavir): preliminary results of ACTG 315 [abstract]. Fourth Conference on Retroviruses and Opportunistic Infection 1997; Jan 22-26:208
11. Vanham G, Edmonds K, Qing L, et al. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol 1996; 103:30-34
12. Wallis RS, Vjecha M, Amir-Tahmasseb M, et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated 2-microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167:43-48